DJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 2.94% to $520.66 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 2.02% to 7,175.83 and Dow Jones Industrial Average falling 2.19% to 49,097.06.
Vertex Pharmaceuticals Inc. closed 8.44% below its 52-week high of $568.67, which the company achieved on November 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 0.86% to $283.54, Krystal Biotech Inc. (KRYS) rose 0.15% to $315.82, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 5.47% to $7.60.
Data source: Dow Jones Market Data, FactSet. Data compiled November 19, 2026.